Source: Annual Congress 2011 - ECDC and WHO tuberculosis guidelines: update 2011 (organised within the FP7 funded TB-PAN-NET project)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Falzon (Geneva, Switzerland). The WHO Guidelines for the Programmatic Management of drug-resistant TB: the 2011 update - recommendations and evidence. Annual Congress 2011 - ECDC and WHO tuberculosis guidelines: update 2011 (organised within the FP7 funded TB-PAN-NET project)

Member's Comments

No comment yet.

Related content which might interest you: The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011 2015 guidelines to treat IPF: an update of the 2011 guidelines - specific treatment recommendations Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015 Improving the TB case management: the International Standards for Tuberculosis care Source: Guideline 2006 Year: 2006 Improving the TB case management: the International Standards for Tuberculosis care Source: Eur Respir J 2006 Oct 01;28(4):687-690 Year: 2006 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Childhood tuberculosis outbreaks in EU/EEA: A systematic review Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update Source: Eur Respir J 2003; 22: 1 Year: 2003 The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Programme PG10 Tuberculosis management: a personalised clinical approach Source: International Congress 2016 – PG10 Tuberculosis management: a personalised clinical approach Year: 2016 Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 2015 guidelines to treat IPF: an update from the 2011 guidelines - METHODOLOGY Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015 Community acquired pneumonia guidelines: not only treatment indications Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis Year: 2004 Implementing asthma self-management – A systematic review of implementation studies Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area Source: Eur Respir J, 53 (1) 1802077; 10.1183/13993003.02077-2018 Year: 2019 MDR-TB guidelines: what is new on clinical management Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management Year: 2020 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Steps of bedaquline implementation in Georgia Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Insights into the process used to develop the Official 2015 ATS/ERS/JRS/ALAT Clinical Practice Guidelines: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Clinical Practice Guideline Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015 The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations Source: International Congress 2019 – Managing drug-resistant tuberculosis: from new guidelines to clinical practice Year: 2019